Avista Pharma Solutions, Inc. dba Cambrex
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 104 Gold St, Agawam, Massachusetts (MA) 01001-3807, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 1220785 · DUNS 079509111
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-07-25
- VAIDrug Quality Assurance2019-12-18
- NAIDrug Quality Assurance2018-09-05
- VAIDrug Quality Assurance2016-06-15
- VAIDrug Quality Assurance2013-09-27
- NAIDrug Quality Assurance2010-10-27
Drugs this plant is listed as making
3 distinct drugs across 4 products name this site in their FDA label.
- Irinotecan HydrochlorideIpsen Biopharmaceuticals, Inc.
- Sodium ThiosulfateFennec Pharmaceuticals Inc.
- TocilizumabBiogen MA Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.